Analyst Research
| Report Title | Price |
|---|---|
|
Provider: ValuEngine, Inc.
|
$127.00
|
|
Provider: Stock Traders Daily
|
$58.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Stock Traders Daily
|
$495.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
CentraState Healthcare System Selects Cognizant Technology Solutions Corp. For Developing ICD-10 Transition Strategy
Cognizant Technology Solutions Corp. announced that it has been selected by CentraState Healthcare System, a not-for-profit community health organization, to develop a strategy for transitioning to ICD-10. As part of the engagement, Cognizant will perform a comprehensive ICD-10 assessment to determine the clinical, administrative, and financial impact on business and IT processes, staff, and partners, and recommend an implementation strategy to enable a smooth transition to ICD-10 and meet the 2013 compliance deadline.
Latest Developments for Cognizant Technology Solutions Corp
- Cognizant Technology Solutions Corp Issues Q2 2013 Guidance; Revenue Guidance Above Analysts' Estimates; Reaffirms FY 2013 Guidance
- Cognizant Technology Solutions Corp Issues Q1 2013 Guidance; EPS Guidance Above Analysts' Estimates; Issues FY 2013 Guidance Above Analysts' Estimates
- Cognizant Technology Solutions Corp To Acquire Six Companies Of C1 Group
- Cognizant Technology Solutions Corp Issues Q4 2012 Guidance In Line With Analysts' Estimates; Reaffirms FY 2012 Revenue Guidance; Raises FY 2012 EPS Guidance
- Share this
- Link this
- Digg this
Follow Reuters